Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prinomastat + Gem/Cis in Advanced NSCLC
NCT00004199Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 1999
- Primary completion
- Jul 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prinomastat in non-small cell lung cancer (NSCLC), sponsored by Pfizer. Started Mar 1999; status: completed.
02
Drugs
prinomastat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00004199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004199.